top of page
Pastel Gradient Background
EoSight Logo with shadow.png

Transforming Chronic Rhinosinusitis Care through Point-of-Care Diagnostics
 

Our Team.

EoSight was founded by scientists from Pharma, Academia, and Healthcare.

  • LinkedIn
  • LinkedIn
  • LinkedIn
alignment.png

Technology

EoSwab™ and EoTracker™ are our molecular biomarker-based diagnostic technologies. 

Please check our recent peer-reviewed publications:

  • An Eosinophil Peroxidase Activity Assay Accurately Predicts Eosinophilic Chronic Rhinosinusitis: Link

  • An eosinophil peroxidase activity assay predicts acute exacerbations in post-operative CRS: Link

bottom of page